Novosense(SH:688052)2024-04-25 10:24Financial Performance - The corrected total operating revenue for 2023 is RMB 131,092.72 million, a decrease of 21.52% compared to the previous year's adjusted revenue of RMB 167,039.27 million[3]. - The corrected net profit attributable to the parent company is RMB -30,533.48 million, a decrease of 22.02% from the previously forecasted range of RMB -25,023.57 to -20,473.83 million[5]. - The corrected net profit attributable to the parent company after deducting non-recurring gains and losses is RMB -39,312.07 million, a decrease of 13.97% compared to the previous forecast[5]. - The basic earnings per share is corrected to RMB -1.66, reflecting a decline of 179.63% from the previous year's earnings of RMB 2.70[3]. Assets and Equity - The total assets at the end of the reporting period are RMB 723,248.80 million, an increase of 4.36% compared to the previous year's adjusted total assets of RMB 686,067.85 million[4]. - The equity attributable to the parent company is RMB 627,537.79 million, a decrease of 4.48% from the previous year's adjusted equity of RMB 649,754.60 million[4]. Future Plans and Investments - The company plans to continue significant investments in R&D, which will impact future taxable income and deferred tax assets[5]. Communication and Transparency - The company has communicated with the auditing firm to ensure the accuracy of the financial statements and has made timely adjustments[6]. - The company expresses apologies for any inconvenience caused by the corrections and urges investors to be aware of investment risks[7]. - The company will provide detailed financial data in its 2023 annual report available on the Shanghai Stock Exchange website[6].